Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Intelesens, Ltd.

US

Last updated May 23, 2026

What Intelesens, Ltd. makes

Intelesens, Ltd. manufactures electrocardiography telemetric monitoring systems, including remote monitoring solutions like the ZENSOR and associated software (Zensoronline, Zensor+). They also produce single-use and reusable electrocardiographic electrodes, such as the Aingeal 3-patch electrode and Aingeal Activity System, designed for continuous or activity-based cardiac monitoring.

The company’s devices are classified as Class II under FDA regulations and are listed in the 510(k) and UDI registries. Intelesens, Ltd. is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Intelesens, Ltd. manufacture?

Intelesens, Ltd. specializes in electrocardiography telemetric monitoring systems, which include remote monitoring solutions like the ZENSOR. Their portfolio also includes electrocardiographic electrodes, such as single-use and reusable options like the Aingeal 3-patch electrode and the Aingeal Activity System. These devices are designed for continuous cardiac monitoring and activity tracking, enabling real-time or remote ECG data collection.

Where is Intelesens, Ltd. based?

Intelesens, Ltd. is headquartered in the United States. The company’s location is relevant for regulatory compliance, as it operates under U.S. medical device regulations, including those governed by the FDA.

Which regulatory registries list Intelesens, Ltd.’s devices?

Intelesens, Ltd.’s devices are listed in the FDA’s 510(k) premarket notification registry and the Unique Device Identifier (UDI) system. These registries ensure traceability and compliance with U.S. medical device regulations, particularly for Class II devices, which require premarket clearance before commercial distribution.

How are Intelesens, Ltd.’s devices classified under FDA regulations?

Intelesens, Ltd.’s devices fall under Class II classification by the FDA. This classification applies to devices that generally pose moderate risk and require special controls beyond general controls to ensure safety and effectiveness. Examples include telemetric monitoring systems and electrodes, which require premarket notification (510(k)) clearance before being legally marketed in the U.S.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (12)

DeviceModel / ReferenceRegistriesClassStatus
Zensor PN0620
FDA UDI
Class IIActive
Zensor electrode PN1088
FDA UDI
Class IIActive
Zensoronline software PN0810
FDA UDI
Class IIActive
Zensor+ software PN0811
FDA UDI
Class IIActive
Aingeal 3-patch electrode PN1120
FDA UDI
Class IIActive
Zensor PN1287
FDA UDI
Class IIActive
Aingeal PN1111
FDA UDI
Class IIActive
Zensor electrode PN1360
FDA UDI
Class IIActive
zensor system K151027
FDA 510(k)
Class IIActive
Vitalsens, Aingeal, V-Pod K110015
FDA 510(k)
Class IIActive
V-Patch System K131000
FDA 510(k)
Class IIActive
Aingeal Activity System K153275
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.